Our PCR tests are processed at a privately-owned, high complexity. CLIA-certified laboratory with the ability to turn around test results in 4 to 6 hours or less when ordered. The samples are run on Thermo Fisher Quant Studio Real-Time PCR machines which detect changes in gene expressions as low as 1/5 fold.
The Accula SARS-CoV-2 Test combines the accuracy of PCR with the speed and simplicity of rapid antigen tests, delivering visual results in 30 minutes. The test accelerates PCR virus detection using their proprietary Oscillating Amplification Reaction (Oscar) PCR technology that enables shortened thermocycling times and faster PCR completion without the need for costly thermal cycler hardware and optical detection systems used in laboratory-based qPCR. The system delivers rapid, accurate, PCR testing in a self-contained fully integrated single-use cassette and reusable dock.
The Lucira state-of-the-art, single-use molecular tests use RT-Lamp technology to return results in 30 minutes or less. Where RT-PCR tests heat and cool a to quantify viral RNA, the RT-PCR LAMP technology is an isothermal approach to nucleic acid amplification using a single temperature and does not require thermal cycling of PCR. This test has EUA approval from the FDA and is returns percentages of 94% sensitivity and 98% specificity. These tests can be sent anywhere in the world.
Sienna COVID-19 Antigen Rapid Test RAPID RESULTS IN 10-15 MINUTES *The Sienna Antigen Test is good for all variants of Covid-19 Sars 2 since it detects an integral part of the nucleocapsid that is common to all Covid-19 variants.
EUA-authorized rapid Antibody Tests test for both IgM and IgG Antibodies. IgM is the first antibody produced by the immune system when a virus attacks. A positive IgM test indicates that you may have been infected and that your immune system has started responding to the virus. IgG antibodies that develop in most patients within seven to 10 days after symptoms of COVID-19 begin. IgG antibodies remain in the blood after an infection has passed. These antibodies indicate that you may have had COVID-19 in the recent past and have developed antibodies that may protect you from future infection. It is unknown at this point how much protection antibodies might provide against reinfection.
A rapid, qualitative test authorized by the FDA under an EUA for detecting influenza type A, influenza type B and SARS CoV-2 antigens. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. Within 15 minutes, from an anterior nasal swab, this test detects nucleocapsid antigen from SARS-CoV-2, influenza A and/or influenza B.
Testing Hollywood now offers, Visby Medical’s test for COVID-19, the first PCR-based, single-use test that is easy to use, fits in the palm of your hand, and returns results in less than 30 minutes. By eliminating the long lead time to results and integrating the entire PCR process into one machine, Visby’s invention eliminates the limitations in turn around time inherent in lab-bound PCR tests, the gold standard of infectious disease testing. Visby Medical COVID-19 test has been authorized by the FDA under the EUA for the qualitative detection of SARS-CoV-2 RNA.
Our rapid, point-of-care antigen test have been granted an EUA from the FDA. Tests provide a real time, on the spot readout in 10 minutes.